Latest "Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite" News Stories

19:18 EDT 5th July 2015 | BioPortfolio

Here are the most relevant search results for "Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite" found in our extensive news archives from over 250 global news sources.

More Information about Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite for you to read. Along with our medical data and news we also list Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite Clinical Trials, which are updated daily. BioPortfolio also has a large database of Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite Companies for you to search.

Showing "Enhancement bone formation transduced MSCs biomimetic nano hydroxyapatite" News Articles 1–25 of 3,800+

Extremely Relevant

Pharmaceutical Research: Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation

Type: Original PaperPurposeBioceramic(Hydroxyapatite) based Poly(D,L-lactide-co-glycolide) (PLGA) and polyethylene glycol (PEG) nanoparticles of Risedronate was prepared by dialysis method for bone-targeting.MethodsRisedronate, a targeting moiety tha...

Bone marrow cell transplants used to treat fractures, lung injury, and renal obstruction

(Cell Transplantation Center of Excellence for Aging and Brain Repair) Mesenchymal stem cells have been transplanted to successfully treat several diseases and conditions. MSCs, which have the ability to self-renew and differentiate into specialized ...

Balancing bone formation and degradation key to osteoporosis treatment

Most existing treatments for pathological bone loss inhibit osteoclasts (bone-destroying cells) to limit bone degradation. However, by doing this, they also prevent bone formation since it is stimulated by the presence of these very same osteoclast c...

Novel Compositions for Use as Bone Scaffolds and Enhancers of Bone Regeneration

This invention is directed to the discovery that a mixture of an organic polymer and inorganic particles may hold therapeutic utility as a biomaterial for artificial bone scaffolds, injectable bone-filling materials, and enhancement of new bone generation. This composition has demonstrated utility in vivo in mice.

Role of a master gene in skeletal formation probed by researcher

The runx2 master transcription factor functions differently in chondrocytes and osteoblasts, two key cells in bone formation, scientists report. This research has taken a major step forward in understanding the bone development function of a gene cal...

Relevant

The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur

The AAPS Journal: Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes

Type: Original PaperMesenchymal stromal/stem cells (MSCs) have demonstrated favorable wound healing properties in addition to their differentiation capacity. MSCs encapsulated in biomaterials such as gelatin and polyethylene glycol (PEG) composite hy...

Bone: Osteocyte-specific activation of the canonical Wnt–β catenin pathway stimulates bone formation

Inhibiting Bone Turnover Could Prevent Bone Mets in Breast Cancer

An inhibitor of osteoclast formation can stop the proliferation of dormant tumor cells that in some breast cancer survivors turn into bone metastases.

Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms

Myeloproliferative neoplasms (MPNs) are diseases caused by mutations in the haematopoietic stem cell (HSC) compartment. Most MPN patients have a common acquired mutation of Janus kinase 2 (JAK2) gene in HSCs that renders this kinase constitutively ac...

Study reveals bone-building protein's impact on bone stem cells

A new study by UCLA researchers shows that administering the protein NELL-1 intravenously stimulates significant bone formation through the regenerative ability of stem cells.

The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase

Tumour metastasis is a complex process involving reciprocal interplay between cancer cells and host stroma at both primary and secondary sites, and is strongly influenced by microenvironmental factors such as hypoxia. Tumour-secreted proteins play a ...

Ferring Pharmaceuticals acquires BioSET orthobiologic product candidates

Ferring Pharmaceuticals, based in Saint Prex, Switzerland, has acquired the assets of Maryland-based BioSurface Engineering Technologies (BioSET), including two phase III ready orthobiologic product candidates designed to improve bone repair. The in...

Gold 'nano-drills'

Spherical gold particles are able to 'drill' a nano-diameter tunnel in ceramic material when heated. This is an easy and attractive way to equip chips with nanopores for DNA analysis, for example. Nanotechnologists of the University of Twente publish...

Infants with rare bone disease improve bone formation after cell transplantation

Recent research carried out by a team of researchers in Japan has investigated the use of bone marrow transplants (BMTs) to treat hypophosphatasia (HPP). In this study, the researchers carried out BMT for two infants with HPP in combination with allo...

Supramolecular nesting of cyclic polymers

Biopolymers adopt functional tertiary structures through folding and multiplex formation. Synthetic molecules with protein-like dimensions — monodisperse cyclic porphyrin polymers with diameters of 13–21 nm — have now been shown to exhibit bi...

In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via 14C-TdR labeling

Background: In order to shed light on the regenerative mechanism of mesenchymal stem cells (MSCs) in vivo, the bio-distribution profile of implanted cells using a stable and long-term tracking method is needed. We herein investigated the bio-distribu...

Growing New Bones without a Human Body

EpiBone is a small startup in Harlem specializing in a unique method, which allows patients to “grow their own bone.” The company utilizes a small bioreactor to produce autologous bone grafts made from data collected by CT scans as well as stem cells gathered from the patient. EpiBone’s website says its process “is strategically positioned to provide a superior bone graft that will provide...

Mice stem cells capable of regenerating bone, cartilage

Brett Smith for redOrbit.com - Your Universe Online Researchers at Columbia University Medical Center (CUMC) have announced the discovery of a new stem cell in mice that is capable of regenerating both bone and cartilage, according to a new report in the journal Cell. The study team found the new cells by following the activity of a protein called Gremlin1. When they transplanted the cells, call...

Cynata achieves world-first MSC breakthrough

The company has successfully validated its method of consistently and efficiently manufacturing MSCs using the stem cells during testing at Waisman Biomanufacturing in the US.Induced pluripotent stem cells are an effectively limitless starting material, unlike other methods of producing MSCs, which require a continuous supply of new tissue donations.Cynata expects to be able to produce all the MSC...

It’s Time To Bone Up: A Guide to Bone Health

By Diane L. Schneider, MD As we age, bone loss is inevitable—but we cannot feel it or see it. You want to prevent the end result: breaking a bone. One in two women over the age of 50 will break a bone. Your risk for a fracture increases with age, a...

Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Products from BioSET

Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET), including two phase III ready orthobiologic product candidates designed to improve bone repair. The initial indications for...

Live assessment of blood formation

Since ancient times, humankind has been aware of how important blood is to life. Naturalists speculated for thousands of years on the source of the body's blood supply. For several centuries, the liver was believed to be the site where blood forms. I...

Stem cell discovery may lead to targeted osteoarthritis treatment

Targeted stem cell treatments for osteoarthritis inch closer after Arthritis UK researchers find individual stem cells that can regenerate tissue, cartilage and bone. The findings are reported in Stem Cell Reports. The stem cells are mixed within human bone marrow stromal cells (MSCs) but are so similar in appearance that scientists previously had difficulty in […] The post Stem cell discove...

Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET

Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET), including two phase III ready orthobiologic product candidates designed to improve bone repair. The initial indications for AMPLEX® and PREFIX® to be investigated are fusion in foot/ankle and lumbar spine surgical procedures, res...



Advertisement
 
Advertisement
 

News Quicklinks